Culture & Sensitivity (Swab for KLB) at Dr. Essa Lab

Culture & Sensitivity (Swab for KLB) at Dr. Essa Lab

The Culture & Sensitivity (Swab for KLB) at Dr. Essa Lab is a highly specialized microbiological diagnostic test designed to identify the presence of Corynebacterium diphtheriae, the causative bacterium of diphtheria. Historically referred to as the Klebs-Löffler Bacillus (KLB), this pathogen is responsible for an acute, highly contagious, and potentially life-threatening infection of the upper respiratory tract. The primary clinical objective of this test is to isolate the bacteria from a patient’s throat, tonsils, or nasopharynx, confirm its identity through microscopic and biochemical analysis, and perform antibiotic susceptibility testing to guide targeted antimicrobial therapy. This diagnostic investigation is vital for clinical decision-making, patient management, and public health surveillance, particularly in regions where diphtheria remains endemic or sporadic outbreaks occur.

Corynebacterium diphtheriae is a Gram-positive, non-motile, pleomorphic bacillus. When it colonizes the mucosal surfaces of the upper respiratory tract, typically the tonsils, pharynx, or larynx, the bacterium can produce a highly potent exotoxin. This toxin inhibits cellular protein synthesis by inactivating elongation factor-2 (EF-2), leading to localized tissue necrosis. The necrotic tissue, combined with inflammatory cells, fibrin, and bacterial colonies, forms a characteristic thick, leathery, greyish-white pseudomembrane. If left untreated, this membrane can expand rapidly, causing acute upper airway obstruction. Furthermore, systemic absorption of the diphtheria toxin can lead to severe, life-threatening complications, including acute myocarditis, peripheral demyelinating neuropathy, and acute renal failure. Therefore, rapid and accurate laboratory identification via a swab for KLB is critical for initiating prompt treatment with diphtheria antitoxin and appropriate antibiotics.

At Dr. Essa Lab, the Culture & Sensitivity (Swab for KLB) test utilizes advanced microbiological techniques to ensure the highest level of diagnostic accuracy. The process begins with the careful collection of a swab from the affected mucosal site, followed by immediate inoculation onto selective and differential culture media. These media, such as Löffler’s serum medium and Tellurite agar, are specifically formulated to support the growth of Corynebacterium species while inhibiting normal oral flora. Subsequent microscopic examination using specialized stains, such as Albert’s stain, allows microbiologists to visualize the characteristic metachromatic granules of the bacillus. Finally, antibiotic sensitivity testing is conducted to identify the most effective therapeutic agents, ensuring a comprehensive and evidence-based approach to patient care.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the accuracy of the Culture & Sensitivity (Swab for KLB) at Dr. Essa Lab, patients must adhere to specific preparation guidelines. Proper preparation minimizes the risk of false-negative results and ensures a high-quality clinical specimen. Patients should observe the following instructions:

• Avoid Antibiotic Therapy: If clinically feasible, the swab should be collected before initiating any antibiotic treatment. Antibiotics present in the patient’s system can inhibit bacterial growth on culture media, leading to a false-negative result. If the patient is already taking antibiotics, please inform the laboratory staff and the ordering physician.
• Do Not Use Antiseptic Mouthwashes: Patients must refrain from using antiseptic mouthwashes, oral sprays, or medicated lozenges for at least 4 to 6 hours prior to specimen collection. These substances can temporarily reduce the bacterial load on the mucosal surface, interfering with the culture’s ability to detect the pathogen.
• Fasting Recommendations: While strict fasting is not mandatory, patients are strongly advised to avoid eating, drinking, or brushing their teeth for at least 1 hour before the procedure. This precaution helps prevent the stimulation of the gag reflex during the throat swab, reducing discomfort and the risk of vomiting.
• Inform the Laboratory of Symptoms: Patients or guardians should provide a brief clinical history to the laboratory staff, including the onset of symptoms, vaccination status, and any known exposure to confirmed cases of diphtheria.

During the Procedure

The collection of a throat or nasopharyngeal swab for KLB is a quick, safe, and standardized clinical procedure performed by trained healthcare professionals at Dr. Essa Lab. The process is conducted with strict adherence to infection control and biosafety protocols:

• Patient Positioning: The patient is asked to sit comfortably in a well-lit area, tilt their head back slightly, and open their mouth as wide as possible. For pediatric patients, a parent or guardian may be asked to assist in holding the child still to ensure safety and accuracy.
• Visualization of the Pharynx: The healthcare professional uses a sterile, disposable tongue depressor to gently press down the tongue, allowing a clear and unobstructed view of the tonsils, posterior pharyngeal wall, and any visible lesions or membranes.
• Specimen Collection: Using a sterile Dacron, polyester, or calcium alginate swab, the clinician carefully rubs the swab over the inflamed areas, tonsillar crypts, and the edges of any visible pseudomembrane. If a pseudomembrane is present, the swab is gently applied beneath the membrane or to a portion of the membrane itself, as this is where the active bacteria are most concentrated. Care is taken to avoid touching the tongue, cheeks, or uvula to prevent contamination with normal oral flora.
• Transport and Safety: The swab is immediately placed into a sterile transport tube containing Stuart’s or Amies transport medium. This ensures the viability of the bacteria during transit to the microbiology laboratory. The entire collection process takes less than 30 seconds. While the patient may experience a brief gag reflex or mild discomfort, the procedure is entirely non-invasive and safe.

When is a Culture & Sensitivity (Swab for KLB) Performed?

Clinical Suspicion of Respiratory Diphtheria

Physicians order a Culture & Sensitivity (Swab for KLB) when a patient presents with classic clinical signs of respiratory diphtheria. The most prominent indication is the presence of a thick, adherent, greyish-white pseudomembrane covering the tonsils, pharynx, or larynx. This membrane is highly characteristic of Corynebacterium diphtheriae infection. Patients often present with a sore throat, low-grade fever, hoarseness, and difficulty swallowing. Because diphtheria can progress rapidly to cause airway obstruction, prompt diagnostic swabbing is essential to confirm the clinical suspicion and guide immediate therapeutic intervention with antitoxin and antibiotics.

Evaluation of Severe Bull Neck Lymphadenopathy

Another critical clinical indication for this test is the presence of severe cervical lymphadenopathy accompanied by extensive soft tissue edema in the neck, a clinical sign known as bull neck. This appearance is caused by the systemic absorption of the diphtheria toxin, which triggers intense local inflammation and tissue swelling. When a patient presents with a severe sore throat and a visibly swollen neck, clinicians must immediately suspect diphtheria, especially in unvaccinated or under-vaccinated individuals. The KLB swab helps confirm the bacterial etiology behind this severe presentation, allowing for rapid isolation and treatment.

Screening and Surveillance of Close Contacts

The Culture & Sensitivity (Swab for KLB) is highly important for public health surveillance and outbreak control. When a case of diphtheria is confirmed, public health guidelines mandate the screening of all close contacts, including family members, healthcare workers, and classmates. Many individuals exposed to Corynebacterium diphtheriae may become asymptomatic carriers, harboring the bacteria in their nasopharynx without showing symptoms. These carriers can silently transmit the pathogen to vulnerable, unvaccinated individuals. Swabbing close contacts helps identify these carriers, allowing clinicians to administer prophylactic antibiotics and monitor them closely to prevent further transmission.

Differential Diagnosis of Membranous Pharyngitis

Membranous pharyngitis, characterized by inflammatory exudates or membranes in the throat, can be caused by several pathogens other than Corynebacterium diphtheriae. These include Streptococcus pyogenes (Group A Streptococcus), Epstein-Barr Virus (infectious mononucleosis), Candida albicans (oral thrush), and the anaerobic bacteria responsible for Vincent’s angina. Because the clinical management of these conditions differs significantly, physicians utilize the KLB culture and sensitivity test to definitively rule out or confirm diphtheria. This ensures that patients receive the correct, targeted therapy and avoids the unnecessary administration of highly specific treatments like diphtheria antitoxin.

Investigation of Suspected Cutaneous Diphtheria

While diphtheria is primarily a respiratory infection, Corynebacterium diphtheriae can also infect the skin, causing cutaneous diphtheria. This condition is characterized by chronic, non-healing skin ulcers covered by a greyish, necrotic membrane. Cutaneous diphtheria is more common in tropical regions, crowded living conditions, and among individuals with poor hygiene. Physicians request a swab for KLB from these skin lesions to isolate the bacterium and determine its toxigenicity. Diagnosing cutaneous diphtheria is crucial, as these lesions serve as a significant reservoir for the transmission of the bacteria to the respiratory tract of other individuals.

What Does a Culture & Sensitivity (Swab for KLB) Detect?

The Culture & Sensitivity (Swab for KLB) at Dr. Essa Lab is designed to detect, isolate, and characterize various microbiological parameters. The clinical findings obtained from this comprehensive investigation include:

• Isolation of Corynebacterium diphtheriae: The primary positive finding, indicating the presence of the causative agent of diphtheria in the clinical specimen.
• Absence of Corynebacterium diphtheriae: A negative finding, suggesting that the patient’s symptoms may be due to other viral or bacterial pathogens.
• Presence of Metachromatic Granules: Visualization of Babes-Ernst or metachromatic granules within the bacterial cells using Albert’s or Neisser’s stain, a key microscopic feature of C. diphtheriae.
• Gram-Positive Pleomorphic Rods: Microscopic detection of Gram-positive, club-shaped bacilli arranged in characteristic Chinese-letter or V patterns.
• Growth on Löffler’s Serum Medium: Rapid growth of creamy, moist, greyish-white colonies within 12 to 18 hours, which is highly suggestive of Corynebacterium species.
• Growth on Tellurite Agar: Development of characteristic grey-to-black colonies due to the reduction of potassium tellurite by the bacteria.
• Toxigenicity Status (Elek’s Test Positive): Confirmation that the isolated strain produces the diphtheria toxin, which is responsible for the severe systemic manifestations of the disease.
• Toxigenicity Status (Elek’s Test Negative): Identification of a non-toxigenic strain of C. diphtheriae, which, while still capable of causing localized pharyngitis, does not produce the systemic toxin.
• Detection of tox Gene via PCR: Molecular confirmation of the presence of the gene responsible for toxin production, providing a rapid and highly sensitive diagnostic result.
• Susceptibility to Penicillin: Determination that the isolated strain is sensitive to penicillin, a first-line antibiotic used to eradicate the bacteria and stop toxin production.
• Susceptibility to Erythromycin: Confirmation of sensitivity to erythromycin, which is commonly used as an alternative first-line agent, especially in penicillin-allergic patients.
• Resistance to Erythromycin: Detection of bacterial resistance to erythromycin, indicating the need for alternative antimicrobial therapy.
• Susceptibility to Azithromycin: Evaluation of the pathogen’s sensitivity to azithromycin, a macrolide antibiotic with favorable dosing schedules.
• Susceptibility to Clindamycin: Assessment of sensitivity to clindamycin, which may be considered in specific clinical scenarios.
• Presence of Streptococcus pyogenes: Co-isolation of Group A Streptococcus, which can cause concurrent pharyngitis or mimic diphtheria symptoms.
• Presence of Staphylococcus aureus: Identification of secondary bacterial pathogens that may complicate the clinical course of the infection.
• Overgrowth of Candida Species: Detection of fungal overgrowth, which can cause pseudomembranous oral thrush, a key differential diagnosis.
• Isolation of Corynebacterium pseudodiphtheriticum: Identification of this non-pathogenic commensal organism, which is part of the normal upper respiratory flora and must be differentiated from C. diphtheriae.
• Isolation of Corynebacterium ulcerans: Detection of another Corynebacterium species that can carry the tox gene and cause diphtheria-like symptoms, often transmitted through raw milk or contact with animals.
• Heavy Growth of Normal Oral Flora: A finding indicating that only normal, non-pathogenic bacteria (such as viridans streptococci and Neisseria species) were isolated, with no pathogens detected.
• Intermediate Susceptibility to Targeted Antimicrobials: Identification of borderline resistance to specific antibiotics, guiding clinicians to adjust dosages or select alternative agents.
• Negative Culture After 48 Hours: Final confirmation of no growth of Corynebacterium diphtheriae or other significant pathogens after the standard incubation period.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that timely diagnostic results are critical, especially when dealing with highly infectious diseases like diphtheria. Preliminary results, including microscopic findings from Gram staining and Albert’s staining, are typically available within 12 to 24 hours of specimen collection. These initial findings provide clinicians with immediate, valuable clues to support presumptive diagnosis and early patient isolation. The final culture report, which includes definitive bacterial identification on selective media and antibiotic susceptibility testing (AST), is generally completed within 48 to 72 hours. This timeframe is necessary to allow for the proper incubation and growth of the bacteria, ensuring the highest level of accuracy. Patients and healthcare providers can easily access reports online through the secure Dr. Essa Lab web portal or mobile application using their unique patient ID, or they can collect printed reports from any of our conveniently located diagnostic centers.

Culture & Sensitivity (Swab for KLB) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Specimen Adequacy	Satisfactory swab with sufficient cellular and bacterial material	Unsatisfactory due to dry swab, inadequate sampling, or contamination
Direct Smear (Albert’s Stain)	No metachromatic granules observed; normal cellular debris	Green-stained bacilli with dark blue/black polar metachromatic granules (suggestive of C. diphtheriae)
Gram Stain	Gram-positive cocci and Gram-negative rods consistent with normal oral flora	Gram-positive pleomorphic, club-shaped bacilli arranged in L or V patterns (Chinese-letter appearance)
Culture on Löffler’s Medium	No growth of Corynebacterium diphtheriae	Rapid growth of small, greyish-white, opaque colonies suggestive of Corynebacterium species
Culture on Tellurite Agar	No growth of black or grey colonies	Growth of characteristic grey-to-black colonies with peripheral halos (indicative of C. diphtheriae)
Toxigenicity (Elek’s Test)	Non-toxigenic strain (No precipitin lines formed)	Toxigenic strain (Visible precipitin lines indicating active diphtheria toxin production)
PCR for tox Gene	Negative for the tox gene	Positive for the tox gene, confirming the presence of a toxigenic strain of C. diphtheriae
Antibiotic Susceptibility	Not applicable (no pathogen isolated)	Pathogen isolated with documented sensitivity or resistance to Penicillin, Erythromycin, or Clindamycin

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Culture & Sensitivity (Swab for KLB)?

• Experienced Healthcare Professionals: Our clinical team consists of highly qualified pathologists, microbiologists, and laboratory technologists dedicated to providing accurate diagnostic services.
• Patient-Focused Care: We prioritize patient comfort and safety, ensuring a gentle and professional specimen collection process for individuals of all ages.
• Quality Diagnostic Services: Dr. Essa Lab maintains strict internal and external quality control measures to ensure the reliability of every test result.
• Professional Reporting: We deliver clear, comprehensive, and clinically relevant reports that assist physicians in making timely and informed treatment decisions.
• Modern Diagnostic Approach: Our microbiology department utilizes advanced culture media, staining techniques, and molecular methods to detect pathogens with high sensitivity.
• Comfortable Environment: All our diagnostic centers are designed to provide a clean, safe, and comfortable environment for patients and their families.
• Convenient Location: With an extensive network of branches across Karachi and other major cities, accessing our diagnostic services is easy and convenient.
• Commitment to Accurate Diagnosis: Since our establishment in 1987, we have remained committed to delivering trusted diagnostic insights to support public health and patient care.